Clinical Trials on Pulmonary Disorders in United Kingdom

Total 62770 results

Royal Brompton & Harefield NHS Foundation Trust
Medical Research Council; The Hillingdon Hospitals NHS Foundation Trust; West...

Completed

Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?

Respiratory Tract Diseases | Lung Diseases | Disease Progression | Lung Diseases, Obstructive | Pulmonary Disease, Chronic Obstructive | Pulmonary Emphysema | Bronchitis, Chronic

United Kingdom
University of Southampton

Completed

Improving Monitoring of Patients Receiving Case Management

Hypertension | Diabetes | Chronic Obstructive Pulmonary Disease | Coronary Heart Disease | Multiple Conditions

United Kingdom
GlaxoSmithKline

Completed

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

Pulmonary Disease, Chronic Obstructive

United Kingdom, Netherlands
GlaxoSmithKline
ICON plc

Completed

FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Optimising the Propranolol Block Model

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients (Imperial)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Pulmonary Disease, Chronic Obstructive

United Kingdom
Boehringer Ingelheim

Completed

Effectiveness of Triple Therapy in COPD

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old

Pulmonary Disease, Chronic Obstructive

United Kingdom
Spiration, Inc.

Completed

European Multi-center Post Market Study of the IBV Valve System (IBV)

Chronic Obstructive Pulmonary Disease

Spain, Germany, Italy, Austria, Belgium, United Kingdom
Pneumacare Ltd
Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Norfolk and Suffolk Primary and Community Care and other collaborators

Unknown

Thora-3Di™ Respiratory Rate Validation

Pulmonary Disease

United Kingdom
AstraZeneca
RTI Health Solutions

Recruiting

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints (PASS)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Theravance Biopharma
GlaxoSmithKline

Completed

Succinate Salt Version of GSK961081 for Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

First Time in Human Study With GSK1325756

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

Pulmonary Disease, Chronic Obstructive

United Kingdom
Pulmonx Corporation

Completed

Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV

Pulmonary Emphysema

United Kingdom, Switzerland, Germany
Royal United Hospitals Bath NHS Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust; Royal Free Hospital NHS... and other collaborators

Recruiting

Improving Pulmonary Hypertension Screening by Echocardiography (IMPULSE)

Pulmonary Hypertension

United Kingdom
KU Leuven
University of Zurich; University Medical Center Groningen; University of Athens; University of Edinburgh and other collaborators

Completed

Impact of "Telecoaching Program" on Physical Activity in Patients With COPD (MrPAPP)

Pulmonary Disease, Chronic Obstructive

Netherlands, United Kingdom, Belgium, Greece, Switzerland
Galapagos NV

Completed

Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United Kingdom, Ukraine
University of Leicester

Recruiting

Usability and Acceptability Study of the P-STEP Mobile Application

Heart Failure | Chronic Obstructive Pulmonary Disease | Asthma | Type 2 Diabetes | Coronary Heart Disease | Interstitial Lung Disease

United Kingdom
Life Detection Technologies
Royal Free Hospital NHS Foundation Trust

Not yet recruiting

Non-contact Proactive Remote Monitoring of COPD Exacerbations (DetectEx)

COPD Exacerbation

United Kingdom
Royal United Hospitals Bath NHS Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust; Royal Free Hospital NHS... and other collaborators

Not yet recruiting

Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography (DRAPE)

Pulmonary Hypertension

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust

Suspended

Development of Novel Physiological CMR Methods in Health and Disease

Myocardial Infarction | Coronary Artery Disease | Heart Failure | Pulmonary Hypertension

United Kingdom
Imperial College Healthcare NHS Trust

Terminated

Using Step Count to Enhance Daily Physical Activity in Pulmonary Hypertension (STEPinPH)

Hypertension, Pulmonary

United Kingdom
GlaxoSmithKline
Hammersmith Medicines Research; Covance Harrogate

Completed

A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects

Hypertension, Pulmonary

United Kingdom
Sunovion Respiratory Development Inc.

Completed

Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

Chronic Obstructive Pulmonary Disease

United States, United Kingdom
Olawuyi Racett Nigeria Ltd

Completed

Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension (Medlink)

Hypertension | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Myasthenia Gravis | Congestive Heart Failure

United Kingdom
Kingston University
University College London Hospitals; St. George's Hospital, London

Completed

Toward Self-management in ILD

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Chronic Hypersensitivity Pneumonitis | Connective Tissue Related ILD | Fibrotic Lung Disease

United Kingdom
Theravance Biopharma
GlaxoSmithKline

Completed

A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
Maria Joyera Rodríguez

Not yet recruiting

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels (3TR-ICS-COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom, Spain, Netherlands, Germany
Molecure S.A.

Recruiting

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States, United Kingdom
GlaxoSmithKline

Completed

Safety, Blood Levels and Effects of GW642444

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

QTc Study GSK573719+GW642444

Pulmonary Disease, Chronic Obstructive

United Kingdom
Novartis Pharmaceuticals

Terminated

Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients

Pulmonary Arterial Hypertension

Germany, Korea, Republic of, United Kingdom, United States
Theravance Biopharma
GlaxoSmithKline

Completed

Study of GSK961081 in Healthy Volunteer Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

Pulmonary Disease, Chronic Obstructive

United Kingdom
Queen Mary University of London

Completed

Comparison of Pulmonary Vein Isolation Using SmartTouch® Catheter With or Without Real-time Contact Force Data

Atrial Fibrillation | Atrial Fibrillation Ablation | Pulmonary Vein Isolation

United Kingdom
Portsmouth Hospitals NHS Trust
Pfizer

Completed

MISSION COPD - Modern Innovative SolutionS in Improving Outcomes iN COPD (MISSION-COPD)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Valley Medical Research

Completed

The Effect on Depressive Symptoms in ECF Residents With COPD (DISK-02)

Depression | Chronic Obstructive Pulmonary Disease

United States
Imperial College London
Medical Research Council; Mitsubishi Tanabe Pharma Corporation

Completed

Enhancement of in-Vitro GC Function in Patients With COPD

COPD

United Kingdom
GlaxoSmithKline

Completed

Absorption & Elimination of Radiolabelled GSK2269557

Pulmonary Disease, Chronic Obstructive

United Kingdom

Clinical Trials on Pulmonary Disorders in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations